Register HERE!

We are looking forward to coming together for learning and discussion of the latest advances in blood and marrow transplantation and cellular therapeutics. We hope you’ll join us Saturday, April 13, 2019, in Overland Park, Kansas. We invite you to register today and are pleased to provide this look at the day’s agenda, which features our own experts from The University of Kansas Cancer Center as well as honored and renowned guests.

OBJECTIVES

• Discuss the evolving role and advancements in the fields of autologous and allogeneic hematopoietic stem cell transplantation (HSCT) and cellular therapeutics.
• Discuss the advancements of alternative donor transplantation.
• Discuss the importance of risk stratification in treatment decisions for patients with acute and chronic leukemia, lymphoma, multiple myeloma and bone marrow failure syndromes.
• Evaluate the relative importance of age, disease status, cytogenetics and molecular markers as prognostic and predictive factors for patients with hematologic malignancies.
• Articulate the influence of HLA-typing at diagnosis and the timing of HSCT on posttransplant outcomes.
• Discuss and assess treatment options and strategies for patients who are over 60 years of age.
• Discuss and assess optimal treatment strategies and supportive care in the posttransplant phase.
• Review and discuss the latest clinical trials and novel therapies available for patients with hematologic malignancies and bone marrow failure syndromes.

CME CREDITS

AMA PRA Category 1 Credit™ : 6.75 Credit(s) (maximum claimable: 5.25)